Profile picture

Doctor Andrea Rubboli

Santa Maria delle Croci Hospital, Ravenna (Italy)
Membership: FESC Member
Follow
Biography
Andrea Rubboli, MD, FESC is the Director of the Division of Cardiology, Ospedale S. Maria delle Croci, Ravenna, Italy. After earning cum laude both his MD degree and specialization in Cardiology at the University of Bologna Medical School, Italy, he completed subsequent training at Loyola University of Chicago, IL, USA and University of Linköping, Sweden. He has long been interested in the diagnosis and treatment of thrombotic and thromboembolic diseases, and has pioneered the field of antithrombotic treatment of patients with indication for oral anticoagulation, in particular atrial fibrillation, undergoing percutaneous coronary intervention. On this issue, a substantial scientific contribution (also through national and international collaborations) has been produced, leading to the acquisition of international reputation, constant invitation as faculty member to the most important congresses, and involvement in the development of guidelines/international consensus documents.
Logo ESC

Contributor content

Pharmacotherapy to improve outcomes in coronary disease
Session
Pharmacotherapy to improve outcomes in coronary disease
31 August 2025
Non-obstructive coronary artery disease and acute coronary syndromes (1)
Session
Non-obstructive coronary artery disease and acute coronary syndromes (1)
29 August 2025
How to manage acute cardiac problems in patients with cancer
Session
How to manage acute cardiac problems in patients with cancer
2 September 2024
Personalising antithrombotic therapy in patients with cancer: what every cardiologist should know
Session
Personalising antithrombotic therapy in patients with cancer: what every cardiologist should know
31 August 2024
Oral anticoagulant therapy for atrial fibrillation in clinical practice
Session
Oral anticoagulant therapy for atrial fibrillation in clinical practice
31 August 2024
Meet the Experts: de-escalating DAPT in acute coronary syndrome patients to reduce bleeding risk – what safe options do I have?
Session
Meet the Experts: de-escalating DAPT in acute coronary syndrome patients to reduce bleeding risk – what safe options do I have?
25 August 2023
Young Investigator Awards Session in Thrombosis
Session
Young Investigator Awards Session in Thrombosis
25 August 2023
Poster awards and closure of conference
Session
Poster awards and closure of conference
22 October 2022
Thrombosis and anticoagulation in valvular heart disease
Session
Thrombosis and anticoagulation in valvular heart disease
28 August 2022
Young Investigator Awards Session in Thrombosis
Session
Young Investigator Awards Session in Thrombosis
26 August 2022

ESC 365 is supported by